OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis
Cameron N. Calder, Angela T.H. Kwan, Kayla M. Teopiz, et al.
Journal of Affective Disorders (2024) Vol. 356, pp. 753-762
Closed Access | Times Cited: 8

Showing 8 citing articles:

Oral ketamine for rapid reduction of suicidal ideation in major depressive disorder: a midazolam-controlled randomized clinical trial
Asif Seraj, Mohammed Reyazuddin, Rakesh Gaur, et al.
Asian Journal of Psychiatry (2025) Vol. 106, pp. 104413-104413
Closed Access | Times Cited: 1

Esketamine in depression: putative biomarkers from clinical research
Jenessa N. Johnston, Carlos A. Zarate, Mark D. Kvarta
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 5

Increased Interleukin-6 Levels in Responders with Treatment-Resistant Depression After Bright Light Therapy
Biljana Kosanovic Rajacic, Marina Šagud, Dražen Begić, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 295-295
Open Access

Cariprazine in the acute treatment of unipolar and bipolar depression: A systematic review and meta-analysis
João Martins-Correia, Luís Afonso Fernandes, Ryan Kenny, et al.
Journal of Affective Disorders (2024) Vol. 362, pp. 297-307
Open Access | Times Cited: 3

Rapid and long-lasting effects of subcutaneous esketamine on suicidality: An open-label study in patients with treatment-resistant depression
Eduardo Igor Torquato Cardoso Lopes, Patrícia Cavalcanti-Ribeiro, Fernanda Palhano-Fontes, et al.
Journal of Psychiatric Research (2024) Vol. 176, pp. 254-258
Closed Access | Times Cited: 2

Repeated subcutaneous esketamine on treatment-resistant depression: An open-label dose titration study
Fernanda Palhano-Fontes, Patrícia Cavalcanti-Ribeiro, Kaike Thiê da Costa Gonçalves, et al.
Journal of Affective Disorders (2024)
Closed Access | Times Cited: 2

Functional Connectivity Between Glutamate Receptor Antagonism and Insulin Pathways: Implications for Modeling Mechanism of Action of Ketamine/Esketamine and Dextromethorphan in Depression Treatment
Sabrina Wong, Gia Han Le, Rodrigo B. Mansur, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 10, Iss. 3, pp. 241-243
Closed Access

Esketamine Nasal Spray: Rapid Relief for TRD and Suicide Prevention—Mechanisms and Pharmacodynamics
Hui Song, Yang Luo, Lingzhi Fang
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2059-2071
Open Access

Page 1

Scroll to top